Provided by Tiger Trade Technology Pte. Ltd.

Vaxcyte, Inc.

65.02
-1.9450-2.90%
Post-market: 65.660.6450+0.99%19:59 EDT
Volume:3.85M
Turnover:251.02M
Market Cap:9.67B
PE:-8.50
High:67.97
Open:67.14
Low:63.79
Close:66.96
52wk High:90.75
52wk Low:39.87
Shares:148.81M
Float Shares:136.00M
Volume Ratio:0.48
T/O Rate:2.83%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.6496
EPS(LYR):-5.6333
ROE:-36.51%
ROA:-22.61%
PB:3.51
PE(LYR):-11.54

Loading ...

Portable MRI Maker Hyperfine's Q3 Prelim Revenue Beats Estimates; FY Outlook Reaffirmed

Reuters
·
Yesterday

Vaxcyte SVP Finance, CAO Elvia Cowan Disposes of 19,000 Common Shares for $1,647,060

Reuters
·
Yesterday

US Stocks on the MOVE-Halozyme, Moderna, Merck

Reuters
·
Yesterday

U.S. Stocks on the MOVE-Halozyme, BKV, AppFolio

Reuters
·
Yesterday

Analysts Conflicted on These Healthcare Names: BridgeBio Pharma (BBIO) and Vaxcyte (PCVX)

TIPRANKS
·
Oct 07

U.S. Stocks on the MOVE-Intel, Vaxcyte, Constellation Brands

Reuters
·
Oct 07

Vaxcyte 7.412M share Spot Secondary priced at $64.00

TIPRANKS
·
Oct 07

Why Vaxcyte Chose A 1.5% Convertible

Macro World​
·
Oct 07

Vaxcyte Announces Pricing of Public Offerings and $500 Million Convertible Notes Due 2032

Reuters
·
Oct 07

Vaxcyte Prices USD 500 Million Convertible Senior Notes Offering Due 2032

Reuters
·
Oct 07

Vaxcyte - Common Stock Offered at $64 Per Share; Pre-Funded Warrants at $64; Exercise Price $0.001

THOMSON REUTERS
·
Oct 07

Vaxcyte - Announces Pricing of Public Offerings and $500 Mln Convertible Notes Due 2032

THOMSON REUTERS
·
Oct 07

Vaxcyte Announces Pricing of Concurrent Public Offerings of Common Stock, Pre-Funded Warrants and Convertible Senior Notes

THOMSON REUTERS
·
Oct 07

Market Movers | Option Care Health Surges 33%; SpaceX Gains 2%; Nvidia Rises 1%; SK hynix Falls 3%

Tiger Newspress
·
Oct 06

Movement Alert|Vaxcyte, Inc. Falls 5.92% in Regular Trading, Equity Dilution Concerns Following Public Offering Announcement

Market Focus
·
Oct 06

Vaxcyte Down After Starting $1 Bln Stock, Convertible Offerings

Reuters
·
Oct 06

US Research Roundup-Affiliated Managers Group, Goldman Sachs, Vaxcyte

Reuters
·
Oct 06

Vaxcyte Shares Fall 3.4% Premarket After Co Commences Public Offering of Stock, Warrants and Convertible Notes

THOMSON REUTERS
·
Oct 06

Lonza to Add New Revenue Driver with Vaxcyte's Pneumonia Shot

Dow Jones
·
Oct 06

Vaxcyte, Inc. : Needham Raises Target Price to $122 from $110

THOMSON REUTERS
·
Oct 06